ES2627437T3 - Composiciones de fosfolípido para cuidado de lentes de contacto y preservación de composiciones farmacéuticas - Google Patents

Composiciones de fosfolípido para cuidado de lentes de contacto y preservación de composiciones farmacéuticas Download PDF

Info

Publication number
ES2627437T3
ES2627437T3 ES08755679.1T ES08755679T ES2627437T3 ES 2627437 T3 ES2627437 T3 ES 2627437T3 ES 08755679 T ES08755679 T ES 08755679T ES 2627437 T3 ES2627437 T3 ES 2627437T3
Authority
ES
Spain
Prior art keywords
days
compound
hours
phospholipid
aeruginosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08755679.1T
Other languages
English (en)
Spanish (es)
Inventor
Malay Ghosh
Masood A. Chowhan
L. Wayne. SCHNEIDER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2627437T3 publication Critical patent/ES2627437T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
    • A01N57/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing acyclic or cycloaliphatic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Eyeglasses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES08755679.1T 2007-05-18 2008-05-16 Composiciones de fosfolípido para cuidado de lentes de contacto y preservación de composiciones farmacéuticas Active ES2627437T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93893907P 2007-05-18 2007-05-18
US938939P 2007-05-18
PCT/US2008/063877 WO2008144494A1 (en) 2007-05-18 2008-05-16 Phospholipid compositions for contact lens care and preservation of pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2627437T3 true ES2627437T3 (es) 2017-07-28

Family

ID=39627450

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08755679.1T Active ES2627437T3 (es) 2007-05-18 2008-05-16 Composiciones de fosfolípido para cuidado de lentes de contacto y preservación de composiciones farmacéuticas

Country Status (15)

Country Link
US (2) US20080287395A1 (enExample)
EP (1) EP2155271B1 (enExample)
JP (1) JP5620264B2 (enExample)
KR (1) KR20100016091A (enExample)
CN (1) CN101678140A (enExample)
AR (1) AR066901A1 (enExample)
AU (1) AU2008254858B2 (enExample)
BR (1) BRPI0811188A2 (enExample)
CA (1) CA2683283A1 (enExample)
CL (1) CL2008001462A1 (enExample)
ES (1) ES2627437T3 (enExample)
MX (1) MX2009011713A (enExample)
TW (1) TW200904485A (enExample)
UY (1) UY31094A1 (enExample)
WO (1) WO2008144494A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110010788A (ko) * 2008-05-28 2011-02-07 알콘 리서치, 리미티드 자기보존 에멀젼
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength
US20100160342A1 (en) * 2008-12-22 2010-06-24 Alcon Research, Ltd. Compositions of Topical Ocular Solutions to Deliver Effective Concentrations of Active Agent to the Posterior Segment of the Eye
CN101473832B (zh) * 2009-02-17 2012-05-09 上海斯贝生物科技有限公司 一种新型环保型消毒液
JP2011021002A (ja) * 2009-06-16 2011-02-03 Lion Corp 眼科用組成物
TWI547522B (zh) * 2009-07-07 2016-09-01 愛爾康研究有限公司 環氧乙烷環氧丁烷嵌段共聚物組成物
BR112012028308B1 (pt) * 2010-05-05 2021-09-28 Alcon Inc. Formulações oftálmicas de galactomanano estabilizadas, e seu método de fabricação
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
US10130576B2 (en) * 2012-11-13 2018-11-20 Johnson & Johnson Consumer Inc. Oral care compositions
US20140134115A1 (en) * 2012-11-13 2014-05-15 Mcneil-Ppc, Inc. Oral care compositions
US9248928B2 (en) * 2012-12-21 2016-02-02 Coopervision International Holding Company, Lp Methods of manufacturing contact lenses for delivery of beneficial agents
CA2966489A1 (en) * 2014-11-03 2016-05-12 Nicolai Vladimirovich Bovin Antimicrobial surface treatment
US9744192B2 (en) * 2015-03-16 2017-08-29 Lee A. Flippin Methods of treating chronic rhinosinusitis
CN108310442B (zh) * 2017-01-17 2021-08-27 台北科技大学 眼科用组合物
GB201813229D0 (en) 2018-08-14 2018-09-26 Ocutec Ltd Formulation
CN110200015B (zh) * 2019-05-21 2020-10-30 乐清市泰博恒电子科技有限公司 一种抗病毒生物肽护理液及其制备方法和应用
WO2021156623A1 (en) 2020-02-07 2021-08-12 Ocutec Limited Optimised contact lens package
CN113729039A (zh) * 2021-08-27 2021-12-03 上海罗克环控节能科技股份有限公司 一种绿色环保消毒液及其制造方法
US20240118559A1 (en) 2022-09-27 2024-04-11 Coopervision International Limited Sustained release of oleic acid from contact lenses

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407791A (en) * 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4923699A (en) * 1988-06-03 1990-05-08 Kaufman Herbert E Eye treatment suspension
US5089053A (en) * 1989-11-09 1992-02-18 Polymer Technology Corporation Contact lens cleaning material and method
US5648348A (en) * 1991-10-28 1997-07-15 Mona Industries, Inc. Phospholipid antimicrobial compositions
US5286719A (en) * 1991-10-28 1994-02-15 Mona Industries, Inc. Phospholipid virucidal compositions
ES2153365T3 (es) * 1991-10-28 2001-03-01 Dennis L Fost Composiciones fosfolipidas antimicrobianas.
JPH08507884A (ja) * 1993-03-12 1996-08-20 アラーガン、インコーポレイテッド フェロモン添加剤を含有するアイケア用品およびその使用方法
CA2098429A1 (en) * 1993-03-30 1994-10-01 Yvette Lynn Touchet Preserved wet wipes
EP0724622A1 (en) * 1993-07-01 1996-08-07 Allergan, Inc. Contact lens cleaning solution based on quaternary ammonium phosphate esters
AU2277395A (en) * 1994-04-11 1995-10-30 Allergan, Inc. Phospholipid preservation of hydrogen peroxide-containing compositions
CA2166722A1 (en) * 1994-05-06 1995-11-16 Manoj L. Maniar Use of vitamin e tocopheryl derivatives in ophthalmic compositions
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US5660858A (en) * 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
IL127955A0 (en) * 1996-07-11 1999-11-30 Farmarc Nederland Bv Pharmaceutical composition containing acid addition salt of basic drug
WO1998006381A1 (en) * 1996-08-09 1998-02-19 Alcon Laboratories, Inc. Preservative systems for pharmaceutical compositions containing cyclodextrins
US6120758A (en) * 1998-07-16 2000-09-19 Shaklee Corporation Preservative system for topically applied products
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US20030207890A1 (en) * 2001-02-23 2003-11-06 Collier Robert J Compounds with 5-ht1a activity useful for treating disorders of the outer retina
AR031135A1 (es) * 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
JP2004262812A (ja) * 2003-02-28 2004-09-24 Rohto Pharmaceut Co Ltd 眼圧低下剤
DE10347994A1 (de) * 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung
US6969706B1 (en) * 2004-05-12 2005-11-29 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins
DE102006051512A1 (de) * 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
MX2009000885A (es) * 2006-07-25 2009-02-05 Osmotica Corp Soluciones oftalmicas.
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
GB0623838D0 (en) * 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength

Also Published As

Publication number Publication date
UY31094A1 (es) 2008-07-03
KR20100016091A (ko) 2010-02-12
EP2155271B1 (en) 2017-03-08
CA2683283A1 (en) 2008-11-27
US20150209466A1 (en) 2015-07-30
JP2010527933A (ja) 2010-08-19
CN101678140A (zh) 2010-03-24
AR066901A1 (es) 2009-09-23
WO2008144494A8 (en) 2009-12-10
CL2008001462A1 (es) 2009-01-02
BRPI0811188A2 (pt) 2014-10-07
EP2155271A1 (en) 2010-02-24
WO2008144494A1 (en) 2008-11-27
US20080287395A1 (en) 2008-11-20
AU2008254858B2 (en) 2013-06-20
TW200904485A (en) 2009-02-01
AU2008254858A1 (en) 2008-11-27
MX2009011713A (es) 2009-11-10
JP5620264B2 (ja) 2014-11-05

Similar Documents

Publication Publication Date Title
ES2627437T3 (es) Composiciones de fosfolípido para cuidado de lentes de contacto y preservación de composiciones farmacéuticas
ES2324058T3 (es) Solucion oftalmica de bimatoprost mejorada.
ES2584858T3 (es) Composiciones farmacéuticas acuosas que contienen complejos de borato-poliol
KR101059711B1 (ko) 2-아미노-3-(4-브로모벤조일)페닐아세트산 함유 수성액제
JP4322503B2 (ja) 水性消毒系
CN1732255B (zh) 多功能表面活性剂清洗隐形眼镜的用途
JP2011515393A (ja) 改善された有効性を示すリン酸塩緩衝眼科用溶液
US20100303930A1 (en) N-halamine formulations with enhanced antimicrobial activity
ES2561034T3 (es) Uso de bis-aminas para incrementar la actividad antimicrobiana de composiciones acuosas
US20080275121A1 (en) N-halogenated amino acid formulations and methods for cleaning and disinfection
JP5296953B1 (ja) 非イオン性ソフトコンタクトレンズ用消毒液
US9694021B2 (en) Pharmaceutical compositions with phosphonium antimicrobial agents
AU2013344497B2 (en) Aqueous liquid composition containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
AU2009288277B2 (en) Pharmaceutical composition having relatively low ionic strength
US20050124702A1 (en) Use of organic buffering agents to enhance the antimicrobial activity of pharmaceutical compositions
ES2695180T3 (es) Composiciones oftálmicas sinérgicas para desinfectar lentes de contacto
JP2004203867A (ja) 眼科用保存剤
WO2004052403A1 (ja) 眼科用保存剤
SK500932014U1 (sk) Očná instilácia na liečbu očnej hypertenzie a glaukómu s obsahom prostaglandínového derivátu F2-alfa, latanoprostu